Gene Symbol | FBP1 |
Entrez ID | 2203 |
Uniprot ID | P09467 |
Description | fructose-bisphosphatase 1 |
Chromosomal Location | chr9: 94,603,133-94,640,249 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0005986 |
sucrose biosynthetic process |
The chemical reactions and pathways resulting in the formation of sucrose, the disaccharide fructofuranosyl-glucopyranoside. |
IBA |
BP |
GO:0006000 |
fructose metabolic process |
The chemical reactions and pathways involving fructose, the ketohexose arabino-2-hexulose. Fructose exists in a open chain form or as a ring compound. D-fructose is the sweetest of the sugars and is found free in a large number of fruits and honey. |
TAS |
BP |
GO:0006001 |
fructose catabolic process |
The chemical reactions and pathways resulting in the breakdown of fructose, the ketohexose arabino-2-hexulose. |
IEA |
BP |
GO:0006002 |
fructose 6-phosphate metabolic process |
The chemical reactions and pathways involving fructose 6-phosphate, also known as F6P. The D-enantiomer is an important intermediate in glycolysis, gluconeogenesis, and fructose metabolism. |
IDA |
BP |
GO:0006094 |
gluconeogenesis |
The formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. |
IEA|IMP|ISS|TAS |
BP |
GO:0006111 |
regulation of gluconeogenesis |
Any process that modulates the frequency, rate or extent of gluconeogenesis, the formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. |
IMP |
BP |
GO:0016311 |
dephosphorylation |
The process of removing one or more phosphoric (ester or anhydride) residues from a molecule. |
IDA|IMP |
BP |
GO:0030308 |
negative regulation of cell growth |
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
IDA |
BP |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process |
The chemical reactions and pathways involving fructose 1,6-bisphosphate, also known as FBP. The D enantiomer is a metabolic intermediate in glycolysis and gluconeogenesis. |
IBA |
BP |
GO:0035690 |
cellular response to drug |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
IDA |
BP |
GO:0045820 |
negative regulation of glycolytic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of glycolysis. |
IDA |
BP |
GO:0046580 |
negative regulation of Ras protein signal transduction |
Any process that stops, prevents, or reduces the frequency, rate or extent of Ras protein signal transduction. |
IDA |
BP |
GO:0051289 |
protein homotetramerization |
The formation of a protein homotetramer, a macromolecular structure consisting of four noncovalently associated identical subunits. |
IDA |
BP |
GO:0071286 |
cellular response to magnesium ion |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. |
IDA |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005829 |
cytosol |
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
IBA|ISS|TAS |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0016208 |
AMP binding |
Interacting selectively and non-covalently with AMP, adenosine monophosphate. |
IDA |
MF |
GO:0042132 |
fructose 1,6-bisphosphate 1-phosphatase activity |
Catalysis of the reaction: D-fructose 1,6-bisphosphate + H2O = D-fructose 6-phosphate + phosphate. |
IDA|IMP|TAS |
MF |
GO:0042802 |
identical protein binding |
Interacting selectively and non-covalently with an identical protein or proteins. |
IPI |
MF |
GO:0046872 |
metal ion binding |
Interacting selectively and non-covalently with any metal ion. |
IMP |
MF |
GO:0048029 |
monosaccharide binding |
Interacting selectively and non-covalently with any monosaccharide. Monosaccharides are the simplest carbohydrates; they are polyhydroxy aldehydes H[CH(OH)]nC(=O)H or polyhydroxy ketones H[CHOH]nC(=O)[CHOH]mH with three or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides. |
ISS |
Domain ID | Description |
---|---|
IPR000146 |
Fructose-1,6-bisphosphatase class 1 |
IPR020548 |
Fructose-1,6-bisphosphatase, active site |
IPR028343 |
Fructose-1,6-bisphosphatase |
IPR033391 |
Fructose-1-6-bisphosphatase class I, N-terminal |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa00010 |
Glycolysis / Gluconeogenesis |
KEGG |
hsa00030 |
Pentose phosphate pathway |
KEGG |
hsa00051 |
Fructose and mannose metabolism |
KEGG |
hsa01100 |
Metabolic pathways |
KEGG |
hsa01200 |
Carbon metabolism |
KEGG |
hsa04152 |
AMPK signaling pathway |
KEGG |
hsa04910 |
Insulin signaling pathway |
KEGG |
hsa04922 |
Glucagon signaling pathway |
KEGG |
WP3915 |
Angiopoietin Like Protein 8 Regulatory Pathway |
WikiPathways |
WP534 |
Glycolysis and Gluconeogenesis |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0009375 |
Colonic Neoplasms |
C0016756 |
Fructose-1,6-Diphosphatase Deficiency |
C0030567 |
Parkinson Disease |
C0038356 |
Stomach Neoplasms |
C2239176 |
Liver Carcinoma |
Tissue | Cell Type |
---|---|
duodenum |
glandular cells |
kidney |
cells in tubules |
liver |
hepatocytes |
small intestine |
glandular cells |
Database Name |
---|
GWASdb |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
BMPR1A |
657 |
P36894 |
0.49 |
ERBB2 |
2064 |
P04626 |
0.49 |
MSH2 |
4436 |
P43246 |
0.49 |
AXIN2 |
8313 |
Q9Y2T1 |
0.49 |
FBXW7 |
55294 |
Q969H0 |
0.49 |
FLCN |
201163 |
Q8NFG4 |
0.49 |
ACTN1 |
87 |
P12814 |
0.63 |
ASL |
435 |
P04424 |
0.63 |
HSPA8 |
3312 |
P11142 |
0.63 |
ATP5J2 |
9551 |
P56134 |
0.63 |
USP22 |
23326 |
Q9UPT9 |
0.63 |
PCNX4 |
64430 |
Q63HM2 |
0.63 |
ASCC2 |
84164 |
Q9H1I8 |
0.63 |
RNF183 |
138065 |
Q96D59 |
0.63 |
FXR2 |
9513 |
P51116 |
0.73 |
LNX1 |
84708 |
Q8TBB1 |
0.73 |
PARK2 |
5071 |
O60260 |
0.75 |
FBP2 |
8789 |
O00757 |
0.88 |
FBP1 |
2203 |
P09467 |
0.96 |
ACTN3 |
89 |
Q08043 |
0.00 |
APC |
324 |
P25054 |
0.49 |
BRAF |
673 |
P15056 |
0.49 |
BUB1 |
699 |
O43683 |
0.49 |
CTNNA1 |
1495 |
P35221 |
0.49 |
DCC |
1630 |
P43146 |
0.49 |
PTPRJ |
5795 |
Q12913 |
0.49 |
RB1 |
5925 |
P06400 |
0.49 |
STK11 |
6794 |
Q15831 |
0.49 |
TLR2 |
7097 |
O60603 |
0.49 |
BCL10 |
8915 |
O95999 |
0.49 |
MLH3 |
27030 |
Q9UHC1 |
0.49 |
BCL2L1 |
598 |
Q07817 |
0.63 |
CSNK1E |
1454 |
P49674 |
0.63 |
DYNC1I1 |
1780 |
O14576 |
0.63 |
KLRC2 |
3822 |
P26717 |
0.63 |
PTK2 |
5747 |
Q05397 |
0.63 |
HDAC6 |
10013 |
Q9UBN7 |
0.63 |
CCDC68 |
80323 |
Q9H2F9 |
0.63 |
ST6GALNAC5 |
81849 |
Q9BVH7 |
0.63 |
MGC39584 |
441058 |
N/A |
0.63 |
AMPH |
273 |
P49418 |
0.72 |
TERF1 |
7013 |
P54274 |
0.73 |
POT1 |
25913 |
Q9NUX5 |
0.73 |
BIN1 |
274 |
O00499 |
0.78 |